Chase Leavitt was named General Counsel of Oncternal Therapeutics on April 19, 2021, according to GlobeNewswire.
| Name | Chase Leavitt |
|---|---|
| Role | General Counsel |
| Company | Oncternal Therapeutics |
| Move | Appointment |
| Date | April 19, 2021 |
| Source | GlobeNewswire |
Who is the general counsel of Oncternal Therapeutics?
Chase Leavitt took the General Counsel role at Oncternal Therapeutics in April 2021, as reported by GlobeNewswire. Legal leadership changes often, so check Oncternal Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.
Other general counsel moves in April 2021
- Jim Jacobson Named General Counsel of Q-State Biosciences (April 30, 2021)
- Edward Sebold Named General Counsel of Kyndryl (April 30, 2021)
- Claudia Cantarella Named General Counsel of Broadway Technology (April 30, 2021)
- Barbara Levi Named Group General Counsel of UBS (April 30, 2021)
- Joanne Bal Named General Counsel of Vital Farms (April 29, 2021)
- Gina Beredo Named General Counsel of Owens Corning (April 29, 2021)
- D. Brock Denton Named General Counsel of Cintas (April 29, 2021)
- Alejandra Carvajal Named Chief Legal Officer of Mersana (April 29, 2021)
Planning your own next move?
- General Counsel and Chief Legal Officer jobs
- Deputy General Counsel jobs
- Open legal jobs at Oncternal Therapeutics on GoInhouse
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: GlobeNewswire. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.